Medtronic PLC MDT
- Market cap
- $112.2B
- P/E
- 21.7×
Follow MDT
Medtronic PLC (MDT) Price to free cash flow
As of 25 September 2026, Medtronic PLC (MDT) trades at a price to free cash flow of 18.5×. Over the past ten years it has ranged from 12.5× (January 2015) to 38.2× (April 2021); the current reading is higher than 10% of that period. That is below the Medical Devices industry median of 22.5× and below the Healthcare sector median of 19.5×.
Price to free cash flow, daily
Annual
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2026 | 19.1× | (8.98%) |
| FY2025 | 21.0× | 2.58% |
| FY2024 | 20.5× | (22.19%) |
| FY2023 | 26.3× | 13.68% |
| FY2022 | 23.2× | (35.74%) |
| FY2021 | 36.0× | 65.80% |
| FY2020 | 21.7× | 6.78% |
| FY2019 | 20.4× | (32.28%) |
| FY2018 | 30.1× | 46.48% |
| FY2017 | 20.5× | (23.45%) |
Quarterly
| Period | Price to free cash flow | Change |
|---|---|---|
| Jul 2026 | 17.8× | (6.83%) |
| Apr 2026 | 19.1× | (21.45%) |
| Jan 2026 | 24.4× | 9.02% |
| Oct 2025 | 22.3× | 2.41% |
| 43 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| PHG Koninklijke Philips N.V. compare | 12.9× |
| BSX Boston Scientific Corporation compare | 17.8× |
| MDT Medtronic PLC | 18.5× |
| GEHC GE HealthCare Technologies Inc. compare | 19.1× |
| STE STERIS plc compare | 21.8× |
| SYK Stryker Corporation compare | 22.2× |
| ABT Abbott Laboratories compare | 22.5× |
| DXCM DexCom, Inc. compare | 23.6× |
| EW Edwards Lifesciences Corporation compare | 35.4× |
| Medical Devices industry median | 22.5× |
| Healthcare sector median | 19.5× |
| Market median | 14.0× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on MDT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement